Perphenazine Tablet
Product Images NDC 51407-697

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Perphenazine (NDC 51407-697). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-694-01ol.jpg (51407 694 01ol)

51407-694-01ol.jpg (51407 694 01ol)
These are film-coated tablets, USP with Perphenazine, USP of 2 mg as the active ingredient; available in a bottle of 100 tablets sold only with a prescription. Dosage recommendations are not provided, but the prescribing information is available. For safety purposes, store the tablets in a tightly sealed, lightproof container at room temperature, away from children. The tablets are manufactured by Cadila Healthcare Ltd, marketed by GSMS, and sold in the United States.*
FDA Label Image

51407-695-01ol.jpg (51407 695 01ol)

51407-695-01ol.jpg (51407 695 01ol)
NDC 51407-695-01 is a prescription medication containing 4 mg of Perphenazine, USP per film coated tablet. It is dispensed in a tight, light-resistant container and should be kept out of reach of children. The medication should be stored at room temperature between 20°-25°C (68°-77°F). The dosage should be followed as per the accompanying Prescribing Information. This medication is manufactured by Cadila Healthcare Ltd. and marketed by GSMS, Incorporated in Camarillo, CA 93012 USA.*
FDA Label Image

51407-696-01ol.jpg (51407 696 01ol)

51407-696-01ol.jpg (51407 696 01ol)
NDC 51407-696-01 is a medication called Perphenazine manufactured by Cadila Healthcare Ltd. Each film-coated tablet has 8 mg of Perphenazine, USP. Dosage information can be found on the accompanying prescribing information. It should be dispensed and stored in a tight, light-resistant container and kept out of the reach of children. The medication should be stored at 20°C-25°C (68°F-77°F) and is marketed by GSMS, Incorporated based in Camarillo, CA.*
FDA Label Image

51407-697-01ol.jpg (51407 697 01ol)

51407-697-01ol.jpg (51407 697 01ol)
This is a description of the medication with NDC number 51407-697-01. The medication is called Perphenazine and it comes in the form of tablets that are film coated. Each tablet contains 16 mg of Perphenazine, USP. The dosage information is available in the accompanying Prescribing Information. The medication must be kept in a tight, light-resistant container (USP) and away from children. It should also be stored at 20° - 25°C (68° - 77°F) in a controlled room temperature according to USP standards. The medication is manufactured by Cadila Healthcare Ltd. and marketed by GSMS, Inc. in Camarillo, CA.*
FDA Label Image

Figure (A257f4b8 6a54 4458 B228 292ef12dccb9 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.